NSE filing, NSE: MAL. Summary written from the filing by ALFA Finder's alert engine.
Mangalam Alloys Ltd: key numbers
- Share price
- ₹32.15
- Market cap
- ₹79.37 Cr
- Revenue (annual)
- ₹437.9 Cr
- Net profit (annual)
- ₹14.68 Cr
- P/E (TTM)
- 5.4×Sector 52.8×
- Promoter holding
- 59.74%
- FII holding
- 0.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mangalam Alloys Ltd
All →Mangalam Alloys Other Announcement
Mangalam Alloys Limited submitted the Regulation 74(5) compliance certificate for the quarter ended September 30, 2026. This is a routine regulatory filing.
Mangalam Alloys Management Change
Mangalam Alloys Limited has appointed Mr. Tushar Uttamchand Mehta as the Compliance Officer of the Company, effective October 9, 2026.
Mangalam Alloys Board Meeting Outcome
Mangalam Alloys Limited appointed Mr. Tushar Uttamchand Mehta as the company's Compliance Officer, effective October 9, 2026.
Mangalam Alloys Annual General Meeting
Mangalam Alloys Limited held its 38th Annual General Meeting on September 30, 2026. Business items outlined in the notice were successfully transacted.
Mangalam Alloys Annual General Meeting
Mangalam Alloys Limited has announced the 38th Annual General Meeting will be held on September 30, 2026. The record date for voting eligibility is September 23, 2026.
Mangalam Alloys Board Meeting Outcome
Mangalam Alloys Limited held a board meeting on September 07, 2026. The board approved the Director's Report, AGM notice, and appointment of a scrutinizer.
Other board meeting date announcements
All →HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.